Pharmacokinetic Trials Qualify As Clinical Studies For Pediatrics - PhRMA
Executive Summary
Any study conducted in children should be considered adequate to support a six month pediatric exclusivity extension for a drug under the pediatric provisions of the FDA Modernization Act, the Pharmaceutical Research & Manufacturers of America maintained in April 3 comments submitted to the agency.